This data-based intelligencer will continue to be updated based on new financial documents so that readers can stay modern. Companies must submit with SEC or SEDAR and be modern to be considered for inclusion. When we started this resource in May 2019, quarterly-income companies, more than $ 2.5 million. As the industry has received a scale, since more companies have published, we later raised the minimum, including $ 12.5 million on September 2020. $ 50 million ($ 68.8 million), and the junior list now has at least $ 25 million ($ 34.4 million).
Note about regulated operating income
In May 2019 we added an additional meter, “adjusted operating income” We detailed In our news. The calculation takes the reported operating income and adjusts it for any change in the real value of biological assets required under IFRS accounting. We believe that this adjustment improves the comparison of companies in IFRS and NAS accounting. We note that frequently income can include one-time compensation, inventory writing or public listing costs, and we recommend that readers understand this unterior materials on quarterly finance. Many companies have been transferred from ITMS to NAS Account, which reduced our need to make adjustments. Please note that our ranking includes only actual reported income and not Pro Forma IncomeWe also note that companies with non-Cannabis actions should provide financial statements in the level of sector, which details not only income, but also operating profits, which must have their operating profits. Aurora Canepis is currently (TSX: ACB), Jazz Pharma (NASDAQ: JH) and TILRAY (TSX: TLRY) does not provide this information.
Tracker Inclusion Updates:
On July 27, at the time of our latest update, 16 companies are qualified for the inclusion of senior lists, including $ 13 and 3 in Canadian currency and 3 have had 13 companies. Currently, 13 companies presenting US dollars and 3 that file in Canadian dollars are the Senior lists, 16 in total. The younger list includes 11 companies that make 11 companies in Canadian dollars. The income of the public Cannabis and the income search engine now includes 29 companies. One company, farmland (NASDAQ. In Canada, both junior list names, canopy growth and organ have moved to a senior list.
Companies were reported to be reported in late July
Since our latest update, almost all Armenian companies have announced their June quarterly reports.
Senior and Junior – US Dollar Report
All recently reported all five MSOS, and the results were not particularly impressive. Curaleaf (OTC: Curlf) (TSX: Cura) has saved the income leader, which decreased by 8% a year ago. Thuelieve (OTC: TCNNF) (CSE: TRUL) saw the income unchanged a year ago. Green Thumb Industries (OTC: GTBIF) (CSE: GTII) has experienced an income that increased by 5% compared to the previous year, but operating profits were sharply dipped. Verano Holdings (OTC: VRNOF) (NEO: VRNO) MSOS was 4th place in MSOS, but its income fell a year ago. CRESCO LABS (OTC: CRLBF) (CSE: CL) had the largest biggest MSOS downfall.
Looking ago, all senior list companies reported, although there are several companies in the junior list that have not yet been submitted. Before mid-November, none of the 5 largest MSOs provided for their Q3 financial statements, but here are the current prospect by Learn:
Curaleaf (OTC: Curlf) (TSX: Cura) – Revenues will drop from 4% to 317.2 million dollars, $ 10%
Thuelieve (OTC: TCNNF) (CSE:
Green Thumb Industries (OTC: GTBII) (CSE: GTII) – Revenues are expected to increase by 1% by 291.0 million dollars, 82.3 million dollars
Verano Holdings (OTC: VRNOF) (Neo: VRNO) – Revenues will be reduced from 6% to $ 203.1 million, with an Ebitda, 6% to $ 60.6 million
Cresco Labs (OTC: CLBF) (CSE: CL) – Revenues will be reduced by 9% to $ 163.8 million adjusted eBitda, decreased by $ 36.7 million
Senior and Junior – Canadian Dollar Report
Nipple (NASDAQ: SNDL) (CSE: SNDL) is possible cannabis income and a year ago. Aurora hemp (NASDAQ. ACB) (TSX: ACB) The revenues seen again a year ago, but slipped successively. Canopy (NASDAQ. CGC) (TSX. Weed) had a great operational loss, although it was a decline a year ago. Organic global (NASDAQ. OGI) (TSX. OGI) has shown a large increase in revenue that stimulates achievements.
Currently, there are still calls for senior companies.
Cannabis Cannabis Revenue Tracker is not a proposal by New Cannabis Ventures, and you should not use it as investment advice. Tilde next to the date means an approximate date. All calculations come from sec or sedar files. For any question or licensing requests please Contact usA number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Statistics Canada released January retail sales for the country, with Cannabis sales are declining from December levels, down 8.4% to C$466.1 million, an all-time monthly high. The sequential decrease increased by the same 8.4% on a daily basis due to the same number of days compared to the previous month. December, originally reported at C$503.7 million, was revised slightly higher to C$508.6 million. December sales rose 6.4% from a year ago, up from May’s 8.3% and June’s 7.5%, but better than the previous lowest annual growth since legalization began in September 2024 of -0.9% and -1.6% in October due to the BC strike. Growth was much slower in December at just 3.9%. Total sales are expected to increase by 4.5% to C$5.39 billion in 2024 and by 4.1% to C$5.62 billion in 2025.
An increase in the number of shops as well as a fall in the prices of flowers that attract consumers from the illegal market have boosted sales. In Ontario, the most populous province, sales fell 8.6% from December and 4% from a year ago. Alberta was down 4.7% from December, but up 1% from a year ago. British Columbia was down 9.5% from December but up 31% from a year ago, while Quebec was down 12.5% from December but up 29% from a year ago.
February sales data will be released on April 24.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada has released December retail sales for the country, with Cannabis sales are on the rise from November levels, up 5.3% to C$503.7 million, a new monthly record high. This sequential increase was up 1.9% on a daily basis due to more days than in the previous month. November, originally reported at C$477.9 million, was revised slightly higher to C$478.4 million. December sales rose 2.9% from a year earlier, up from 8.3% in May, 7.5% in June and 6.2% in September. This was also below the 20.3% growth rate in August 2023 and better than the previous lowest annual growth since the start of legalization, which started at -0.9% in September 2024 and then -1.6% in October due to the BC strike, and it was down significantly from the 9.1% growth in December 2024. The previous record level in August was only 1.8% above the previous year’s level. Total sales are expected to increase by 4.5% to C$5.39 billion in 2024 and by 4.1% to C$5.62 billion in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales rose 6.5% from November but fell 4% from a year earlier. Alberta was up 5.7% from November, but down 1% from last year. British Columbia was up 5.2% from November and 22% from a year ago, while Quebec was down 1.6% from November and 10% from a year ago.
January sales data will be released on March 20.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada has released November retail sales for the country, with Cannabis sales are on the rise up 6.6% from October levels to C$477.9 million. This sequential increase is up 10.2% on a daily basis, driven by fewer days compared to the previous month. October, originally reported at C$451.7 million, was revised slightly lower to C$448.5 million. It was hit by a strike in British Columbia in October. Sales rose 4.6% in November from a year earlier, up from 8.3% in May, up from 7.5% in June and 6.2% in September. This was also lower than the 20.3% growth rate in August 2023 and better than the lowest growth rate in the previous year since the start of legalization, which started at -0.9% in September 2024 and then -1.6% in October due to the BC strike, and it was significantly down from the 9.1% growth in December. August’s record level was only 1.8% higher than last year’s index. Total sales are expected to grow 4.5% to C$5.39 billion in 2024 and 4.2% year-to-date in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales fell 5.2% from October and 3% from a year ago. Alberta was down 5.5% from October and 2% from a year ago. British Columbia, which was down 55.0% sequentially in October and 54% year-over-year, was up 250% sequentially in October and 9% year-over-year, while Quebec was down 4.1% in October and 31% year-over-year.
December sales data will be released on February 20.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
